Educational Platform: Severe Asthma
Support programs for Severe Asthma that:
Severe Asthma Audience Groups: Allergists, Pulmonologists, Immunologists, Ear, Nose, & Throat (ENT) Specialists
Educational Platform: Migraine
Support programs for Migraine that:
Migraine Audience Groups: Primary Care Physicians, Neurologists, Headache Specialists, Pain Specialists, Psychiatrists, Nurse Practitioners, Physician Assistants, Nurses, OB-GYN, Pharmacists
Educational Platform: Chronic Leukemia(s)
Support programs for Chronic Leukemia(s) that:
Chronic Leukemia Audience Groups: Medical Oncologists, Radiation Oncologists, Hematologist -Oncologists, Surgical Oncologists, Oncology Nurses, Oncology Pharmacists, Medical Directors, and Pharmacy Directors
Educational Platform: Huntington's Disease
Support programs for Huntington’s Disease that:
Huntington's Disease Audience Groups: Neurologists, Psychiatrists, Nurses, Nurse Practitioners, Physician Assistants, Pharmacists, and Social Workers
Educational Platform: Tardive Dyskinesia
Support programs for Tardive Dyskinesia that:
Tardive Dyskinesia Audience Groups: Neurologists, Psychiatrists, Nurses, Nurse Practitioners, Physician Assistants, and Pharmacists
Educational Platform: Mild to Moderate Asthma
Support programs for Mild to Moderate Asthma outcomes that:
Mild to Moderate Asthma Audience Groups: Allergists, Pulmonologists, Primary Care Physicians, Nurses, Pharmacists, Nurse Practitioners, and Physician Assistants
Educational Platform: Non-Hodgkin’s Lymphoma
Support programs for Non-Hodgkin’s Lymphoma that:
Lymphoma Audience Groups: Medical Oncologists, Radiation Oncologists, Hematologist -Oncologists, Surgical Oncologists, Oncology Nurses, Oncology Pharmacists, Medical Directors, and Pharmacy Directors
Educational Platform: Biosimilars
Support programs for Biosimilars that:
Biosimilars Audience Groups: Oncology & Rheumatology Professionals, including Physicians, Nurses, Physician Assistants, Pharmacists, Medical Directors, and Pharmacy Directors
Educational Platform: Multiple Sclerosis
Support programs for Multiple Sclerosis that:
Multiple Sclerosis Audience Groups: Audience that primarily specializes in the treatment of MS (MS Specialists, Neurologists, etc.) but can also include PCPs, MS Certified Nurses, Nurses, Pharmacists, and Nurse Practitioners, and Physician Assistants
Mild to Moderate Asthma
2018 Therapeutic Areas
Current budget availability for each therapy area is denoted above, in accordance with these categories
Welcome to HCP Grants
The old Request Management System (RMS) is shut down permanently.
To confirm if you have a grant from the old system, the grant ID numbers are letters plus 5 numbers: MED-TD-27322, PED-HD-27302. If you are trying to submit a reconciliation in the old system, please email it to firstname.lastname@example.org. Please show where the Teva funds were used and how much vs. what was submitted and please include outcomes/metrics and an Executive Summary.
As of July 31, 2018, there are no funds remaining for 2018. Please check back in October 2018 for information on 2019 areas of interest and funding availability.
To submit a grant request you must first be registered in the new RMS. Using Google Chrome or Firefox, go here to register: https://webportalapp.com/sp/login/teva-registration.
Once your registration is approved, you will receive an email from the RMS with the submission link (https://webportalapp.com/sp/login/teva-grantrequest) and you will be able to submit a request.
PLEASE NOTE: The address to send refund checks is: Teva Pharmaceuticals, Attention: Medical Education Department, 41 Moores Road, PO Box 4011, Frazer, PA 19355
For any inquiries email: email@example.com or call 800-961-3604. Please include the grant number if applicable.
For Charitable Donations, please go to https://webportalapp.com/sp/signup/teva-charitabledonations.
Teva is committed to conducting business in compliance with all applicable federal and state statutes and regulations.
For any inquiries email: firstname.lastname@example.org or call: 800-961-3604.
Please include the grant number if applicable.